Unknown

Dataset Information

0

MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.


ABSTRACT: MicroRNAs (miRNAs) are key regulators of tumor progression. Based on microarray data, we identified miR-99a as a potential tumor suppressor in breast cancer. Expression of miR-99a is frequently down-regulated in breast cancer tissues relative to normal breast tissues. Reduced miR-99a expression was highly associated with lymph node metastasis and shorter overall survival of patients with breast cancer. Gain- and loss-of-function studies revealed that, miR-99a significantly inhibits breast cancer cell proliferation, migration, and invasion. An integrated bioinformatics analysis identified HOXA1 mRNA as the direct functional target of miR-99a, and this regulation was confirmed by luciferase reporter assay. Furthermore, we showed for the first time that HOXA1 expression is elevated in breast cancer tissues. Knockdown of HOXA1 significantly inhibited breast cancer cell proliferation, migration and invasion, and restoration of HOXA1 partially rescued the inhibitory effect of miR-99a in breast cancer cells. Collectively, our data indicate that miR-99a plays a tumor-suppressor role in the development of breast cancer, and could serve as a potential therapeutic target for breast cancer treatment.

SUBMITTER: Wang X 

PROVIDER: S-EPMC4741726 | biostudies-literature | 2015 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

MicroRNA-99a inhibits tumor aggressive phenotypes through regulating HOXA1 in breast cancer cells.

Wang Xiaolong X   Li Yaming Y   Qi Wenwen W   Zhang Ning N   Sun Mingjuan M   Huo Qiang Q   Cai Chang C   Lv Shangge S   Yang Qifeng Q  

Oncotarget 20151001 32


MicroRNAs (miRNAs) are key regulators of tumor progression. Based on microarray data, we identified miR-99a as a potential tumor suppressor in breast cancer. Expression of miR-99a is frequently down-regulated in breast cancer tissues relative to normal breast tissues. Reduced miR-99a expression was highly associated with lymph node metastasis and shorter overall survival of patients with breast cancer. Gain- and loss-of-function studies revealed that, miR-99a significantly inhibits breast cancer  ...[more]

Similar Datasets

| S-EPMC8086770 | biostudies-literature
| S-EPMC6993250 | biostudies-literature
| S-ECPF-GEOD-22049 | biostudies-other
| S-EPMC6614573 | biostudies-literature
| S-ECPF-GEOD-32617 | biostudies-other
| S-EPMC6208043 | biostudies-literature
| S-EPMC5391170 | biostudies-literature
| S-EPMC6778625 | biostudies-literature
| S-EPMC4353068 | biostudies-literature
| S-EPMC3034897 | biostudies-literature